David M. Goldenberg
2014
In 2014, David M. Goldenberg earned a total compensation of $2.6M as Chairman, Chief Scientific Officer and Chief Patent Officer at Immunomedics, a 62% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $286,403 |
---|---|
Option Awards | $350,035 |
Salary | $584,495 |
Stock Awards | $1,249,026 |
Other | $153,187 |
Total | $2,623,146 |
Goldenberg received $1.2M in stock awards, accounting for 48% of the total pay in 2014.
Goldenberg also received $286.4K in non-equity incentive plan, $350K in option awards, $584.5K in salary and $153.2K in other compensation.
Rankings
In 2014, David M. Goldenberg's compensation ranked 3,472nd out of 13,032 executives tracked by ExecPay. In other words, Goldenberg earned more than 73.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,472 | 73rd |
Manufacturing | 1,225 | 75th |
Chemicals And Allied Products | 397 | 77th |
Drugs | 308 | 77th |
In Vitro and In Vivo Diagnostic Substances | 10 | 86th |
Goldenberg's colleagues
We found two more compensation records of executives who worked with David M. Goldenberg at Immunomedics in 2014.